{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:57:13Z","timestamp":1781009833599,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:00:00Z","timestamp":1793404800000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG024904"],"award-info":[{"award-number":["U19AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30\\u2013AG066507"],"award-info":[{"award-number":["P30\\u2013AG066507"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19\\u2013AG033655"],"award-info":[{"award-number":["U19\\u2013AG033655"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009804","name":"Northern California Institute for Research and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014041","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurobiolaging.2025.10.004","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:21:44Z","timestamp":1761672104000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identifying a proteomics signature of cognitive impairment and dementia in blood and cerebrospinal fluid through a mediation analysis framework"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-348X","authenticated-orcid":false,"given":"Gabriel","family":"Torrealba-Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Calvo-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay R.","family":"Moghekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Kamalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-019-0562-4","article-title":"CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia","volume":"12","author":"Abu-Rumeileh","year":"2019","journal-title":"Alzheimers Res Ther."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.10.004_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib3","doi-asserted-by":"crossref","first-page":"a005108","DOI":"10.1101\/cshperspect.a005108","article-title":"Extracellular matrix: functions in the nervous system","volume":"3","author":"Barros","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"24","key":"10.1016\/j.neurobiolaging.2025.10.004_bib4","doi-asserted-by":"crossref","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","article-title":"Astrocyte biomarkers in alzheimer disease: a systematic review and meta-analysis","volume":"96","author":"Bellaver","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.10.004_bib5","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","article-title":"Astrocyte reactivity influences amyloid-beta effects on tau pathology in preclinical Alzheimer's disease","volume":"29","author":"Bellaver","year":"2023","journal-title":"Nat. Med"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.10.004_bib6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1749-6632.1996.tb34403.x","article-title":"Regulation of APP expression, biogenesis and metabolism by extracellular matrix and cytokines","volume":"777","author":"Beyreuther","year":"1996","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jclinepi.2023.09.005","article-title":"Using mediators to understand effect modification and interaction","volume":"163","author":"Bours","year":"2023","journal-title":"J. Clin. Epidemiol."},{"issue":"7726","key":"10.1016\/j.neurobiolaging.2025.10.004_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res Ther."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.10.004_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/mp.2013.194","article-title":"APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms","volume":"19","author":"Conejero-Goldberg","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.10.004_bib13","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110240","article-title":"Diagnostics and correction of batch effects in large-scale proteomic studies: a tutorial","volume":"17","author":"Cuklina","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5214961","article-title":"Neuron-Glia Interactions in Neural Plasticity: Contributions of Neural Extracellular Matrix and Perineuronal Nets","volume":"2016","author":"Dzyubenko","year":"2016","journal-title":"Neural Plast."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.10.004_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102046","article-title":"Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis","volume":"91","author":"Gaur","year":"2023","journal-title":"Ageing Res Rev."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.10.004_bib17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/jnr.24622","article-title":"Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease","volume":"98","author":"Gomez-Galvez","year":"2020","journal-title":"J. Neurosci. Res"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.10.004_bib18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/acn3.51652","article-title":"A population-based meta-analysis of circulating GFAP for cognition and dementia risk","volume":"9","author":"Gonzales","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"15","key":"10.1016\/j.neurobiolaging.2025.10.004_bib19","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1212\/WNL.0000000000200953","article-title":"CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and ApoE4","volume":"99","author":"Greenberg","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.10.004_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","article-title":"Plasma proteomic profiles predict future dementia in healthy adults","volume":"4","author":"Guo","year":"2024","journal-title":"Nat. Aging"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.10.004_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","article-title":"Plasma proteomic profiles predict future dementia in healthy adults","volume":"4","author":"Guo","year":"2024","journal-title":"Nat. Aging"},{"issue":"16","key":"10.1016\/j.neurobiolaging.2025.10.004_bib22","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.0000000000002590","article-title":"Brain arterial aging and its relationship to Alzheimer dementia","volume":"86","author":"Gutierrez","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.10.004_bib23","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209537","article-title":"Blood Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-Analysis","volume":"103","author":"Holper","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.10.004_bib25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00018-008-8561-9","article-title":"Collagens in the developing and diseased nervous system","volume":"66","author":"Hubert","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1375302","article-title":"Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia","volume":"15","author":"Ingannato","year":"2024","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.10.004_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biom13071094","article-title":"Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study","volume":"13","author":"Kamalian","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s12276-023-01148-0","article-title":"Pathological phenotypes of astrocytes in Alzheimer\u2019s disease","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.10.004_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells12091309","article-title":"GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.10.004_bib30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrn3550","article-title":"Pathophysiology of the brain extracellular matrix: a new target for remyelination","volume":"14","author":"Lau","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2015.07.023","article-title":"Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis","volume":"242","author":"Lind","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib32","article-title":"Progressive Mechanical and Structural Changes in Anterior Cerebral Arteries with Alzheimer's Disease","author":"Liu","year":"2023","journal-title":"Res Sq."},{"issue":"53","key":"10.1016\/j.neurobiolaging.2025.10.004_bib33","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1002\/chem.202000782","article-title":"Extracellular matrix proteins involved in Alzheimer's disease","volume":"26","author":"Ma","year":"2020","journal-title":"Chemistry"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.10.004_bib34","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/jnc.16039","article-title":"Accumulation of extracellular elastin-derived peptides disturbed neuronal morphology and neuron-microglia crosstalk in aged brain","volume":"168","author":"Ma","year":"2024","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.10.004_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10654-022-00864-7","article-title":"APOE epsilon4 and late-life cognition: mediation by structural brain imaging markers","volume":"37","author":"Ma","year":"2022","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2025.107912","article-title":"Using the counterfactual framework to estimate non-intention-to-treat estimands in randomised controlled trials: a methodological scoping review","volume":"153","author":"Medcalf","year":"2025","journal-title":"Contemp. Clin. Trials"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.10.004_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-016-1560-2","article-title":"Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy","volume":"131","author":"Merlini","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.10.004_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrm3902","article-title":"Extracellular matrix assembly: a multiscale deconstruction","volume":"15","author":"Mouw","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.10.004_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9121036","article-title":"Putative autoantigen leiomodin-1 Is expressed in the human brain and in the membrane fraction of newly formed neurons","volume":"9","author":"Nauen","year":"2020","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.10.004_bib40","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.10.004_bib41","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","article-title":"Proteomic changes in Alzheimer's disease associated with progressive Abeta plaque and tau tangle pathologies","volume":"27","author":"Pichet Binette","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.10.004_bib42","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/pmic.200300456","article-title":"Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease","volume":"3","author":"Porchet","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110781","article-title":"Collagens and elastin genetic variations and their potential role in aging-related diseases and longevity in humans","volume":"129","author":"Romero-Ortuno","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcz036","article-title":"Blood-based protein mediators of senility with replications across biofluids and cohorts","volume":"2","author":"Royall","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.1993.tb23047.x","article-title":"The role of extracellular matrix in the processing of the amyloid protein precursor of Alzheimer's disease","volume":"695","author":"Small","year":"1993","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2025.10.004_bib46","series-title":"Sociological methodology","author":"Sobel","year":"2001"},{"issue":"703","key":"10.1016\/j.neurobiolaging.2025.10.004_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq5923","article-title":"Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease","volume":"15","author":"Sung","year":"2023","journal-title":"Sci. Transl. Med"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.10.004_bib48","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s10571-021-01140-0","article-title":"Elastin-derived peptides in the central nervous system: friend or foe","volume":"42","author":"Szychowski","year":"2022","journal-title":"Cell Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/em-2012-0010","article-title":"Mediation analysis with multiple mediators","volume":"2","author":"VanderWeele","year":"2014","journal-title":"Epidemiol. Methods"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.10.004_bib50","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/alz.12538","article-title":"APOE epsilon2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies","volume":"18","author":"Wang","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med"},{"issue":"46","key":"10.1016\/j.neurobiolaging.2025.10.004_bib52","doi-asserted-by":"crossref","first-page":"17513","DOI":"10.1073\/pnas.0602841103","article-title":"Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury","volume":"103","author":"Wilhelmsson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.10.004_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pharmthera.2011.12.008","article-title":"Integrins as receptor targets for neurological disorders","volume":"134","author":"Wu","year":"2012","journal-title":"Pharm. Ther."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.10.004_bib54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/09622802241289559","article-title":"Is inverse probability of censoring weighting a safer choice than per-protocol analysis in clinical trials?","volume":"34","author":"Xuan","year":"2025","journal-title":"Stat. Methods Med Res"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745802500185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745802500185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:57:37Z","timestamp":1781006257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745802500185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"alternative-id":["S019745802500185X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.10.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying a proteomics signature of cognitive impairment and dementia in blood and cerebrospinal fluid through a mediation analysis framework","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}